Roche Holding AG
(OTC:RHHBY)
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
top performing RHHBY trades
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Roche Holding trades made by congress members.
![]() Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Purchase | Aug 15, 2024 | Jul 23, 2024 | House |
![]() Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale | Jul 09, 2024 | Jun 21, 2024 | House |
![]() Daniel GoldmanHouse (D-NY) | $50K - $100K | stock | Sale | Aug 13, 2023 | Jul 10, 2023 | House |
![]() Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale | Jun 11, 2023 | May 16, 2023 | House |
![]() Daniel GoldmanHouse (D-NY) | $1K - $15K | stock | Purchase | Apr 17, 2023 | Mar 31, 2023 | House |
![]() Daniel MeuserHouse (R-PA) | $1K - $15K | stock | Sale (Partial) | Apr 25, 2023 | Mar 27, 2023 | House |
![]() Daniel MeuserHouse (R-PA) | $1K - $15K | stock | Sale | Mar 30, 2023 | Feb 28, 2023 | House |
![]() Daniel GoldmanHouse (D-NY) | $15K - $50K | stock | Sale (Partial) | Mar 20, 2023 | Feb 27, 2023 | House |
![]() Daniel GoldmanHouse (D-NY) | $15K - $50K | stock | Purchase | Feb 24, 2023 | Jan 13, 2023 | House |
![]() Dwight EvansHouse (D-PA) | $1K - $15K | stock | Purchase | Nov 21, 2022 | Nov 14, 2022 | House |
![]() John RutherfordHouse (R-FL) | $1K - $15K | stock | Sale | Apr 19, 2022 | Mar 16, 2022 | House |